MA29243B1 - Agonistes de pyy et leurs utilisations - Google Patents
Agonistes de pyy et leurs utilisationsInfo
- Publication number
- MA29243B1 MA29243B1 MA30123A MA30123A MA29243B1 MA 29243 B1 MA29243 B1 MA 29243B1 MA 30123 A MA30123 A MA 30123A MA 30123 A MA30123 A MA 30123A MA 29243 B1 MA29243 B1 MA 29243B1
- Authority
- MA
- Morocco
- Prior art keywords
- pyy agonists
- pyy3
- npy
- agonist
- receptors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'INVENTION CONCERNE DES VARIANTS DU PYY3-36 ET DES DÉRIVÉS PÉGYLÉS DE CEUX-CI ET DES COMPOSITIONS ET DES PROCÉDÉS UTILES DANS LE TRAITEMENT D'ÉTATS MODULÉS PAR UN AGONISTE DES RÉCEPTEURS NPY Y2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65036605P | 2005-02-04 | 2005-02-04 | |
US73365605P | 2005-11-04 | 2005-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29243B1 true MA29243B1 (fr) | 2008-02-01 |
Family
ID=36175074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30123A MA29243B1 (fr) | 2005-02-04 | 2007-08-03 | Agonistes de pyy et leurs utilisations |
Country Status (33)
Country | Link |
---|---|
US (3) | US20060178501A1 (fr) |
EP (2) | EP2078729A1 (fr) |
JP (1) | JP4314304B2 (fr) |
KR (1) | KR100892545B1 (fr) |
AP (1) | AP2007004069A0 (fr) |
AR (1) | AR052108A1 (fr) |
AT (1) | ATE426614T1 (fr) |
AU (1) | AU2006211039A1 (fr) |
BR (1) | BRPI0606142A2 (fr) |
CA (1) | CA2596977C (fr) |
CY (1) | CY1109054T1 (fr) |
DE (1) | DE602006005902D1 (fr) |
DK (1) | DK1846445T3 (fr) |
DO (1) | DOP2006000025A (fr) |
EA (1) | EA011882B1 (fr) |
ES (1) | ES2322293T3 (fr) |
GT (1) | GT200600038A (fr) |
HR (1) | HRP20090245T1 (fr) |
IL (1) | IL184324A0 (fr) |
MA (1) | MA29243B1 (fr) |
MX (1) | MX2007009389A (fr) |
NL (2) | NL1031067C2 (fr) |
NO (1) | NO20074498L (fr) |
PA (1) | PA8660701A1 (fr) |
PE (1) | PE20061412A1 (fr) |
PL (1) | PL1846445T3 (fr) |
PT (1) | PT1846445E (fr) |
RS (1) | RS50966B (fr) |
SI (1) | SI1846445T1 (fr) |
TN (1) | TNSN07305A1 (fr) |
TW (1) | TWI310038B (fr) |
UY (1) | UY29357A1 (fr) |
WO (1) | WO2006082517A1 (fr) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350968C (zh) | 2001-09-24 | 2007-11-28 | 皇家创新有限公司 | 饮食行为的改进 |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
MXPA05010773A (es) | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos. |
WO2005012484A2 (fr) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Conjugues anticorps-toxines |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
CN101072789B (zh) | 2004-01-08 | 2013-05-15 | 生物种属学股份公司 | 肽的o-连接的糖基化 |
US20050215710A1 (en) * | 2004-03-23 | 2005-09-29 | Gegg Colin V Jr | Chemically modified protein compositions and methods |
US20080300173A1 (en) | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
JP5948627B2 (ja) | 2004-10-29 | 2016-07-20 | レイショファーム ゲーエムベーハー | 線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化 |
EP1858543B1 (fr) | 2005-01-10 | 2013-11-27 | BioGeneriX AG | Facteur de stimulation de colonie de granulocytes glycopegylé |
EP2386571B1 (fr) | 2005-04-08 | 2016-06-01 | ratiopharm GmbH | Compositions et méthodes utilisées pour la préparation de mutants par glycosylation de l'hormone de croissance humaine résistant à la protéase |
AU2006257792A1 (en) * | 2005-06-13 | 2006-12-21 | Mdrna, Inc. | Transmucosal delivery of peptide derivatives |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
EP2380435B1 (fr) * | 2005-08-31 | 2016-05-25 | Kaneka Corporation | Erythropoiétine féline et son procédé de production |
WO2007056191A2 (fr) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Purification de sucre de nucleotide en utilisant des membranes |
WO2007085887A1 (fr) * | 2006-01-27 | 2007-08-02 | Pfizer Products Inc. | Agonistes du pyy et leurs utilisations |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
JP2008069073A (ja) * | 2006-09-12 | 2008-03-27 | Yokohama Tlo Co Ltd | ラクトフェリン複合体及びその製造方法 |
JP2010505874A (ja) | 2006-10-03 | 2010-02-25 | ノヴォ ノルディスク アー/エス | ポリペプチドコンジュゲートの精製方法 |
CN101600448B (zh) * | 2006-10-04 | 2015-11-25 | 诺和诺德公司 | 甘油连接的peg化的糖和糖肽 |
TWI428346B (zh) | 2006-12-13 | 2014-03-01 | Imp Innovations Ltd | 新穎化合物及其等對進食行為影響 |
KR20150064246A (ko) | 2007-04-03 | 2015-06-10 | 바이오제너릭스 게엠베하 | 글리코페길화 g―csf를 이용하는 치료 방법 |
CA2690611C (fr) | 2007-06-12 | 2015-12-08 | Novo Nordisk A/S | Procede ameliore pour la production de sucres de nucleotide |
WO2009108806A1 (fr) | 2008-02-27 | 2009-09-03 | Novo Nordisk A/S | Molécules de facteur viii conjuguées |
WO2010016936A1 (fr) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Compositions pharmaceutiques d'analogues de polypeptide insulinotrope glucose-dépendant |
US10040838B2 (en) * | 2008-11-04 | 2018-08-07 | Janssen Pharmaceutica Nv | CRHR2 peptide agonists and uses thereof |
WO2010067233A1 (fr) | 2008-12-08 | 2010-06-17 | Pfizer Inc. | 1,2,4 triazolo[4,3-a][1,5] benzodiazépin-5(6h)-ones utilisées comme agonistes du récepteur de la cholécystokinine-1 (cck-1r) |
JP2012515760A (ja) | 2009-01-20 | 2012-07-12 | ファイザー・インク | 置換ピラジノンアミド |
WO2010086820A1 (fr) | 2009-02-02 | 2010-08-05 | Pfizer Inc. | Dérivés de 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazépin-6(5h)-yl)phényle |
WO2010089685A1 (fr) | 2009-02-03 | 2010-08-12 | Pfizer Inc. | Dérivés de 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one |
JP2012516885A (ja) | 2009-02-04 | 2012-07-26 | ファイザー・インク | 4−アミノ−7,8−ジヒドロピリド[4,3−d]ピリミジン−5(6H)−オン誘導体 |
US20110319379A1 (en) | 2009-03-11 | 2011-12-29 | Corbett Jeffrey W | Substituted Indazole Amides And Their Use As Glucokinase Activators |
CA2754681C (fr) | 2009-03-11 | 2014-01-07 | Pfizer Inc. | Derives de benzofuranyle utilises comme inhibiteurs de la glucokinase |
EP2408780A2 (fr) | 2009-03-20 | 2012-01-25 | Pfizer Inc. | 3-oxa-7-azabicycloý3,3.1¨nonanes |
AU2010255422B2 (en) | 2009-06-05 | 2014-04-10 | Pfizer Inc. | 1- ( piperidin-4-yl) -pyrazole derivatives as GPR 119 modulators |
US20130072427A1 (en) | 2009-09-23 | 2013-03-21 | Pfizer Inc. | Gpr 119 modulators |
ES2527179T3 (es) | 2009-11-02 | 2015-01-21 | Pfizer Inc. | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol |
EP2499140A1 (fr) | 2009-11-10 | 2012-09-19 | Pfizer Inc. | Inhibiteurs de n2-pyrazolospirocétone acétyl-coa carboxylase |
CN102695708B (zh) | 2009-11-10 | 2014-10-15 | 辉瑞大药厂 | N1-吡唑并螺酮乙酰辅酶a羧化酶抑制剂 |
WO2011061679A1 (fr) | 2009-11-23 | 2011-05-26 | Pfizer Inc. | Imidazo-pyrazoles comme inhibiteurs du gpr119 |
JP5496409B2 (ja) | 2010-03-19 | 2014-05-21 | ファイザー・インク | 2,3ジヒドロ−1h−インデン−1−イル−2,7−ジアザスピロ[3.5]ノナン誘導体およびグレリン受容体のアンタゴニストまたは逆アゴニストとしてのそれらの使用 |
WO2011158149A1 (fr) | 2010-06-18 | 2011-12-22 | Pfizer Inc. | Dérivés de 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one |
US8859577B2 (en) | 2010-09-30 | 2014-10-14 | Pfizer Inc. | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
CA2815169C (fr) | 2010-10-29 | 2015-10-06 | Pfizer Inc. | Inhibiteurs de la n1/n2-lactame acetyl-coa carboxylase |
MX2013006768A (es) | 2010-12-23 | 2013-07-22 | Pfizer | Moduladores de receptor de glucagon. |
EA023517B1 (ru) | 2011-02-08 | 2016-06-30 | Пфайзер Инк. | Модуляторы глюкагонового рецептора |
MX348860B (es) | 2011-04-22 | 2017-06-30 | Pfizer | Derivados de pirazoloespirocetona para usarse como inhibidores de acetil-coa carboxilasa. |
EP2731944A1 (fr) | 2011-07-15 | 2014-05-21 | Pfizer Inc | Modulateurs de gpr 119 |
US8927577B2 (en) | 2011-07-22 | 2015-01-06 | Pfizer Inc. | Quinolinyl glucagon receptor modulators |
JP6043355B2 (ja) | 2011-08-31 | 2016-12-14 | ファイザー・インク | ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物 |
JP6067754B2 (ja) | 2012-02-24 | 2017-01-25 | アルテオジェン インコーポレイテッドAlteogen Inc. | システイン残基を含むモチーフが結合した修飾抗体、前記修飾抗体を含む修飾抗体−薬物複合体及びその製造方法 |
KR20140137404A (ko) | 2012-04-06 | 2014-12-02 | 화이자 인코포레이티드 | 디아실글리세롤 아실트랜스퍼라제 2 억제제 |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
WO2013164730A1 (fr) | 2012-05-04 | 2013-11-07 | Pfizer Inc. | Composés d'hexahydropyrano[3,4-d][1,3]thiazin-2-amine substitués par des hétérocycliques à titre d'inhibiteurs d'app, bace1 et bace2 |
WO2014045162A1 (fr) | 2012-09-20 | 2014-03-27 | Pfizer Inc. | Composés d'hexahydropyrano[3,4-d][1,3]thiazine-2-amine alkyl-substitués |
EP2931731A1 (fr) | 2012-12-11 | 2015-10-21 | Pfizer Inc. | Composés d'hexahydropyrano [3,4-d][1,3]thiazin-2-amine en tant qu'inhibiteurs de bace1 |
CA2893333C (fr) | 2012-12-19 | 2017-10-24 | Pfizer Inc. | Composes hexahydropyrano[3,4-d][1,3]thiazin-2-amine substitues carbocycliques et heterocycliques |
JP2016507551A (ja) | 2013-02-13 | 2016-03-10 | ファイザー・インク | ヘテロアリール置換ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物 |
US9233981B1 (en) | 2013-02-15 | 2016-01-12 | Pfizer Inc. | Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
CA2909045C (fr) | 2013-05-02 | 2022-12-06 | Glaxosmithkline Intellectual Property Development Limited | Peptides therapeutiques |
CA2926568C (fr) | 2013-10-09 | 2017-09-05 | Pfizer Inc. | Antagonistes de recepteur ep3 de prostaglandine |
KR20160098278A (ko) * | 2013-12-20 | 2016-08-18 | 에프. 호프만-라 로슈 아게 | C-말단 아미드화를 위한 펩티딜글라이신 알파-아미드화 모노옥시게나제 (pam) 의 용도 |
HUE039446T2 (hu) | 2014-03-17 | 2018-12-28 | Pfizer | Diacilglicerol-aciltranszferáz-2 inhibitorok metabolikus rendellenességek és kapcsolódó rendellenességek kezelésében történõ alkalmazásra |
MD20160105A2 (ro) | 2014-04-10 | 2017-03-31 | Pfizer Inc. | 2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide |
WO2016092413A1 (fr) | 2014-12-10 | 2016-06-16 | Pfizer Inc. | Composés indoliques et indazoliques qui activent l'ampk |
EP3237401B1 (fr) | 2014-12-22 | 2019-03-06 | Pfizer Inc | Antagonistes de récepteur ep3 de prostaglandine |
WO2016124687A1 (fr) * | 2015-02-04 | 2016-08-11 | Novo Nordisk A/S | Composés pyy sélectifs et leurs utilisations |
EP3766885B1 (fr) | 2015-06-17 | 2022-05-25 | Pfizer Inc. | Composés tricycliques comme inhibiteurs de la phosphodiesterase |
AU2016325665A1 (en) | 2015-09-24 | 2018-03-08 | Pfizer Inc. | N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides |
JP2018534251A (ja) | 2015-09-24 | 2018-11-22 | ファイザー・インク | Bace阻害剤として有用なn−[2−(3−アミノ−2,5−ジメチル−1,1−ジオキシド−5,6−ジヒドロ−2h−1,2,4−チアジアジン−5−イル)−1,3−チアゾール−4−イル]アミド |
JP2018531924A (ja) | 2015-09-24 | 2018-11-01 | ファイザー・インク | テトラヒドロピラノ[3,4−d][1,3]オキサジン誘導体、およびbace阻害剤としてのその使用 |
CN108473469B (zh) | 2015-12-29 | 2020-11-03 | 辉瑞公司 | 作为己酮糖激酶抑制剂的被取代的3-氮杂双环[3.1.0]己烷 |
AR109179A1 (es) | 2016-08-19 | 2018-11-07 | Pfizer | Inhibidores de diacilglicerol aciltransferasa 2 |
WO2019106193A1 (fr) | 2017-12-01 | 2019-06-06 | University Of Copenhagen | Hormone peptidique avec un ou plusieurs o-glycanes |
WO2019210154A1 (fr) * | 2018-04-26 | 2019-10-31 | Colorado State University Research Foundation | Méthodes et compositions pour le suivi de produits végétaux |
BR112021003039A2 (pt) | 2018-08-31 | 2021-05-18 | Pfizer Inc. | combinações para o tratamento de nash/nafld e doenças relacionadas |
WO2020234726A1 (fr) | 2019-05-20 | 2020-11-26 | Pfizer Inc. | Combinaisons comprenant du benzodioxol en tant qu'agonistes de glp-1r destinées à être utilisées dans le traitement de la nash/nafld et de maladies associées |
WO2023283392A1 (fr) * | 2021-07-08 | 2023-01-12 | Gila Therapeutics, Inc. | Compositions et procédés d'activation d'un récepteur neuronal |
WO2023026180A1 (fr) | 2021-08-26 | 2023-03-02 | Pfizer Inc. | Forme amorphe de (s)-2-(5-((3-éthoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tétrahydrofuran-3-yl)pyrimidine-5-carboxamide |
WO2024118524A1 (fr) | 2022-11-28 | 2024-06-06 | Cerevel Therapeutics, Llc | Composés d'azaindole et leur utilisation en tant qu'inhibiteurs de phosphodiestérase |
Family Cites Families (145)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US141985A (en) * | 1873-08-19 | Improvement in sewing-machine tables | ||
US176643A (en) * | 1876-04-25 | Improvement in ironing-tables | ||
US176630A (en) * | 1876-04-25 | Improvement in wagon-locks | ||
US244041A (en) * | 1881-07-12 | Machine for blocking and shaping hats | ||
US2919901A (en) * | 1957-01-25 | 1960-01-05 | Thor Power Tool Co | Drill system with suction |
US5508815A (en) * | 1981-12-14 | 1996-04-16 | Smart Vcr Limited Partnership | Schedule display system for video recorder programming |
US4908713A (en) * | 1981-12-14 | 1990-03-13 | Levine Michael R | VCR Programmer |
US4586158A (en) * | 1983-02-22 | 1986-04-29 | International Business Machines Corp. | Screen management system |
US4708934A (en) | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
US6319685B1 (en) | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
DE229046T1 (de) | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
US4821097A (en) * | 1987-03-05 | 1989-04-11 | General Instrument Corporation | Apparatus and method for providing digital audio on the sound carrier of a standard television signal |
US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
US4930160A (en) * | 1987-09-02 | 1990-05-29 | Vogel Peter S | Automatic censorship of video programs |
US4984152A (en) * | 1987-10-06 | 1991-01-08 | Bell Communications Research, Inc. | System for controlling computer processing utilizing a multifunctional cursor with decoupling of pointer and image functionalities in space and time |
US4827250A (en) * | 1987-10-26 | 1989-05-02 | Tektronix, Inc. | Graphics display system having data transform circuit |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US4991011A (en) * | 1988-12-23 | 1991-02-05 | Scientific-Atlanta, Inc. | Interactive television terminal with programmable background audio or video |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
JP2877509B2 (ja) | 1989-05-19 | 1999-03-31 | アムジエン・インコーポレーテツド | メタロプロテイナーゼ阻害剤 |
US5727060A (en) * | 1989-10-30 | 1998-03-10 | Starsight Telecast, Inc. | Television schedule system |
DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
EP0814159B1 (fr) | 1990-08-29 | 2005-07-27 | GenPharm International, Inc. | Souris transgéniques capables de produire des anticorps hétérologues |
US5293357A (en) * | 1990-09-10 | 1994-03-08 | The Superguide Corporation | Method and apparatus for controlling a television program recording device |
US5247347A (en) * | 1991-09-27 | 1993-09-21 | Bell Atlantic Network Services, Inc. | Pstn architecture for video-on-demand services |
JP2654283B2 (ja) * | 1991-09-30 | 1997-09-17 | 株式会社東芝 | アイコン表示方法 |
US5317391A (en) * | 1991-11-29 | 1994-05-31 | Scientific-Atlanta, Inc. | Method and apparatus for providing message information to subscribers in a cable television system |
US5291554A (en) * | 1992-05-28 | 1994-03-01 | Tv Answer, Inc. | Shared-price custom video rentals via interactive TV |
FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
EP0652950B1 (fr) | 1992-07-24 | 2007-12-19 | Amgen Fremont Inc. | Production d'anticorps xenogeniques |
JPH06139671A (ja) * | 1992-10-27 | 1994-05-20 | Sony Corp | 記録再生システム |
JP2721751B2 (ja) * | 1992-10-30 | 1998-03-04 | ジューキ株式会社 | 自動封入封緘装置におけるカッタユニット |
US5592551A (en) * | 1992-12-01 | 1997-01-07 | Scientific-Atlanta, Inc. | Method and apparatus for providing interactive electronic programming guide |
US5715515A (en) * | 1992-12-02 | 1998-02-03 | Scientific-Atlanta, Inc. | Method and apparatus for downloading on-screen graphics and captions to a television terminal |
US5410326A (en) * | 1992-12-04 | 1995-04-25 | Goldstein; Steven W. | Programmable remote control device for interacting with a plurality of remotely controlled devices |
WO1994014284A1 (fr) * | 1992-12-09 | 1994-06-23 | Discovery Communications, Inc. | Terminal reprogrammable destine a suggerer des programmes presentes dans un systeme de diffusion de programmes de television |
US5600364A (en) * | 1992-12-09 | 1997-02-04 | Discovery Communications, Inc. | Network controller for cable television delivery systems |
US5483277A (en) * | 1992-12-15 | 1996-01-09 | Alcatel Network Systems | Simplified set-top converter for broadband switched network |
US5598524A (en) * | 1993-03-03 | 1997-01-28 | Apple Computer, Inc. | Method and apparatus for improved manipulation of data between an application program and the files system on a computer-controlled display system |
AU685803B2 (en) * | 1993-03-29 | 1998-01-29 | University Of Cincinnati, The | Analogs of peptide YY and uses thereof |
US5594509A (en) * | 1993-06-22 | 1997-01-14 | Apple Computer, Inc. | Method and apparatus for audio-visual interface for the display of multiple levels of information on a display |
US5621456A (en) * | 1993-06-22 | 1997-04-15 | Apple Computer, Inc. | Methods and apparatus for audio-visual interface for the display of multiple program categories |
US5414455A (en) * | 1993-07-07 | 1995-05-09 | Digital Equipment Corporation | Segmented video on demand system |
US5410344A (en) * | 1993-09-22 | 1995-04-25 | Arrowsmith Technologies, Inc. | Apparatus and method of selecting video programs based on viewers' preferences |
US5398071A (en) * | 1993-11-02 | 1995-03-14 | Texas Instruments Incorporated | Film-to-video format detection for digital television |
US5481542A (en) * | 1993-11-10 | 1996-01-02 | Scientific-Atlanta, Inc. | Interactive information services control system |
US5422674A (en) * | 1993-12-22 | 1995-06-06 | Digital Equipment Corporation | Remote display of an image by transmitting compressed video frames representing background and overlay portions thereof |
US5516653A (en) * | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
JPH07244781A (ja) * | 1994-03-07 | 1995-09-19 | C S K Sogo Kenkyusho:Kk | ソフトウェアレンタル方法および装置ならびに流通媒体 |
US5629732A (en) * | 1994-03-29 | 1997-05-13 | The Trustees Of Columbia University In The City Of New York | Viewer controllable on-demand multimedia service |
US5512958A (en) * | 1994-04-29 | 1996-04-30 | Matsushita Electric Corporation Of America | System for controlling the effects of noise in television receivers |
US5521631A (en) * | 1994-05-25 | 1996-05-28 | Spectravision, Inc. | Interactive digital video services system with store and forward capabilities |
JP3575063B2 (ja) * | 1994-07-04 | 2004-10-06 | ソニー株式会社 | 再生装置、再生方法 |
US5596106A (en) | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
EP0699000B1 (fr) * | 1994-08-24 | 2001-06-20 | Hyundai Electronics America | Serveur vidéo et système l'employant |
US5682325A (en) * | 1994-09-12 | 1997-10-28 | Bell Atlantic Network Services, Inc. | Level 1 gateway for video tone networks |
US5619249A (en) * | 1994-09-14 | 1997-04-08 | Time Warner Entertainment Company, L.P. | Telecasting service for providing video programs on demand with an interactive interface for facilitating viewer selection of video programs |
DE4435477A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
US5614940A (en) * | 1994-10-21 | 1997-03-25 | Intel Corporation | Method and apparatus for providing broadcast information with indexing |
JP3025907B2 (ja) | 1994-10-27 | 2000-03-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | アポリポタンパク質−b合成阻害剤 |
US5521186A (en) | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
US5724521A (en) * | 1994-11-03 | 1998-03-03 | Intel Corporation | Method and apparatus for providing electronic advertisements to end users in a consumer best-fit pricing manner |
US5623613A (en) * | 1994-11-29 | 1997-04-22 | Microsoft Corporation | System for displaying programming information |
US5912227A (en) * | 1995-01-27 | 1999-06-15 | North Carolina State University | Method of enhancing nutrient uptake |
US5619247A (en) * | 1995-02-24 | 1997-04-08 | Smart Vcr Limited Partnership | Stored program pay-per-play |
US5632681A (en) * | 1995-03-07 | 1997-05-27 | International Business Machines Corporation | Universal electronic video game renting/distributing system |
US5651010A (en) * | 1995-03-16 | 1997-07-22 | Bell Atlantic Network Services, Inc. | Simultaneous overlapping broadcasting of digital programs |
ATE390933T1 (de) | 1995-04-27 | 2008-04-15 | Amgen Fremont Inc | Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8 |
US5721829A (en) * | 1995-05-05 | 1998-02-24 | Microsoft Corporation | System for automatic pause/resume of content delivered on a channel in response to switching to and from that channel and resuming so that a portion of the content is repeated |
US6558708B1 (en) * | 1995-05-17 | 2003-05-06 | Cedars-Sinai Medical Center | Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
US5740549A (en) * | 1995-06-12 | 1998-04-14 | Pointcast, Inc. | Information and advertising distribution system and method |
US5751282A (en) * | 1995-06-13 | 1998-05-12 | Microsoft Corporation | System and method for calling video on demand using an electronic programming guide |
US5724106A (en) * | 1995-07-17 | 1998-03-03 | Gateway 2000, Inc. | Hand held remote control device with trigger button |
US5745837A (en) * | 1995-08-25 | 1998-04-28 | Terayon Corporation | Apparatus and method for digital data transmission over a CATV system using an ATM transport protocol and SCDMA |
US5737028A (en) * | 1995-11-01 | 1998-04-07 | International Business Machines Corporation | Previous channel listing with cursor controlled user interface for television video displays |
US5919901A (en) * | 1996-04-08 | 1999-07-06 | Bayer Corporation | Neuropeptide Y receptor Y5 and nucleic acid sequences |
US5721897A (en) * | 1996-04-09 | 1998-02-24 | Rubinstein; Seymour I. | Browse by prompted keyword phrases with an improved user interface |
US5721827A (en) * | 1996-10-02 | 1998-02-24 | James Logan | System for electrically distributing personalized information |
EP2262243A1 (fr) * | 1996-12-10 | 2010-12-15 | United Video Properties, Inc. | Appareil pour guide de programme électronique via internet |
US6654933B1 (en) * | 1999-09-21 | 2003-11-25 | Kasenna, Inc. | System and method for media stream indexing |
EP2088188B1 (fr) | 1997-04-16 | 2011-08-31 | Unigene Laboratories, Inc. | Expression directe des peptides dans un milieu de culture |
IL121230A (en) * | 1997-07-03 | 2004-05-12 | Nds Ltd | Intelligent electronic program guide |
US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
BR9812540A (pt) | 1997-09-26 | 2001-12-26 | Athersys Inc | Expressão de genes endógenos por recombinaçãonão homóloga de uma construção de vetor comdna celular |
US6046167A (en) * | 1998-03-25 | 2000-04-04 | University Of Cincinnati | Peptide YY analogs |
US6505348B1 (en) * | 1998-07-29 | 2003-01-07 | Starsight Telecast, Inc. | Multiple interactive electronic program guide system and methods |
US6360053B1 (en) * | 1998-08-07 | 2002-03-19 | Replaytv, Inc. | Method and apparatus for fast forwarding and rewinding in a video recording device |
IL141769A0 (en) | 1998-09-11 | 2002-03-10 | Aventis Pharma Sa | Azetidine derivatives, preparation and medicines containing them |
US20020026638A1 (en) * | 2000-08-31 | 2002-02-28 | Eldering Charles A. | Internet-based electronic program guide advertisement insertion method and apparatus |
FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
EP1189629B1 (fr) * | 1999-02-10 | 2010-09-29 | Curis, Inc. | Peptide yy (pyy) pour traiter des troubles metaboliques du glucose |
US7086077B2 (en) * | 1999-04-01 | 2006-08-01 | Sedna Patent Services, Llc | Service rate change method and apparatus |
US7150031B1 (en) * | 2000-06-09 | 2006-12-12 | Scientific-Atlanta, Inc. | System and method for reminders of upcoming rentable media offerings |
US6986156B1 (en) * | 1999-06-11 | 2006-01-10 | Scientific Atlanta, Inc | Systems and methods for adaptive scheduling and dynamic bandwidth resource allocation management in a digital broadband delivery system |
US6832386B1 (en) * | 1999-06-11 | 2004-12-14 | Scientific-Atlanta, Inc. | System and method for allowing a user to quickly navigate within a program guide to an established reference point |
US7010801B1 (en) * | 1999-06-11 | 2006-03-07 | Scientific-Atlanta, Inc. | Video on demand system with parameter-controlled bandwidth deallocation |
US7228556B2 (en) * | 1999-12-21 | 2007-06-05 | Tivo Inc. | Distributed, interactive television program guide; system and method |
US20030030679A1 (en) * | 2000-01-06 | 2003-02-13 | Anuj Kumar Jain | User-definable images in bookmarks |
WO2001075736A1 (fr) * | 2000-03-31 | 2001-10-11 | Liquid Engines, Inc. | Moteur d'adaptation electronique pour adapter des caracteristiques voulues a des attributs d'articles |
ES2400716T3 (es) * | 2000-03-31 | 2013-04-11 | United Video Properties, Inc. | Sistema y método de medios interactivos para presentar contenido |
US20020007485A1 (en) * | 2000-04-03 | 2002-01-17 | Rodriguez Arturo A. | Television service enhancements |
GB0008691D0 (en) * | 2000-04-07 | 2000-05-31 | Post Impressions Systems Ltd | Input and output systems for data processing |
US7934232B1 (en) * | 2000-05-04 | 2011-04-26 | Jerding Dean F | Navigation paradigm for access to television services |
US8069259B2 (en) * | 2000-06-09 | 2011-11-29 | Rodriguez Arturo A | Managing removal of media titles from a list |
US7685520B2 (en) * | 2000-06-22 | 2010-03-23 | Intel Corporation | Electronic programming guide with selectable categories |
US7962370B2 (en) * | 2000-06-29 | 2011-06-14 | Rodriguez Arturo A | Methods in a media service system for transaction processing |
JP4356226B2 (ja) * | 2000-09-12 | 2009-11-04 | ソニー株式会社 | サーバ装置、配信システム、配信方法、及び端末装置 |
US8302127B2 (en) * | 2000-09-25 | 2012-10-30 | Thomson Licensing | System and method for personalized TV |
WO2002032120A2 (fr) * | 2000-10-11 | 2002-04-18 | United Video Properties, Inc. | Systemes et procedes d'elaboration de listes de medias d'utilisateur |
US20020049978A1 (en) * | 2000-10-20 | 2002-04-25 | Rodriguez Arturo A. | System and method for access and placement of media content information items on a screen display with a remote control device |
US6924291B2 (en) | 2001-01-23 | 2005-08-02 | Merck & Co., Inc. | Process for making spiro isobenzofuranone compounds |
EP1373216B1 (fr) | 2001-03-22 | 2004-12-15 | Solvay Pharmaceuticals B.V. | Derives de 4,5-dihydro-1h-pyrazole ayant une activite d'antagoniste de cb 1 |
MXPA03009566A (es) | 2001-04-19 | 2004-12-06 | Scripps Research Inst | Metodos y composicion para la produccion de pares trna-aminoaciltrna sintetasa ortogonales. |
NZ528752A (en) | 2001-06-28 | 2006-06-30 | Pfizer Prod Inc | Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein B (APO B) secretion |
US8006262B2 (en) * | 2001-06-29 | 2011-08-23 | Rodriguez Arturo A | Graphic user interfaces for purchasable and recordable media (PRM) downloads |
CN100350968C (zh) | 2001-09-24 | 2007-11-28 | 皇家创新有限公司 | 饮食行为的改进 |
US7142590B2 (en) * | 2001-10-11 | 2006-11-28 | Utstarcom Inc. | Method and system for oversubscribing a DSL modem |
US20030074257A1 (en) * | 2001-10-12 | 2003-04-17 | Michael Saveliev | Method and apparatus for advertising adjacent to a beverage dispenser to facilitate advertising income device placement in high traffic venues |
US7334251B2 (en) * | 2002-02-11 | 2008-02-19 | Scientific-Atlanta, Inc. | Management of television advertising |
AU2003219934A1 (en) | 2002-03-06 | 2003-09-22 | Merck And Co., Inc. | Method of treatment or prevention of obesity |
US7423067B2 (en) | 2002-03-26 | 2008-09-09 | Merck & Co., Inc. | Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
ES2301833T3 (es) | 2002-07-29 | 2008-07-01 | Hoffmann La Roche | Derivados de benzodioxol. |
EP1558252B1 (fr) | 2002-08-02 | 2007-10-10 | Merck & Co., Inc. | Derives de furo[2,3-b]pyridine substitues |
US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
MY134457A (en) | 2002-11-22 | 2007-12-31 | Merck & Co Inc | Substituted amides |
US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
CA2510199A1 (fr) | 2002-12-17 | 2004-07-08 | Nastech Pharmaceutical Company Inc. | Compositions et procedes permettant d'ameliorer l'administration aux muqueuses de peptides de liaison du recepteur y2, et procedes pour le traitement et la prevention de l'obesite |
AU2003289118A1 (en) * | 2002-12-18 | 2004-07-09 | International Business Machines Corporation | Web service providing system, server device for the same, control method for controlling computer system as server device for web service providing system, program for executing the control method, and recording medium |
US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US20070027073A1 (en) * | 2003-04-08 | 2007-02-01 | Menachem Rubinstein | Long-acting derivatives of pyy agonists |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
AU2004241242A1 (en) | 2003-05-14 | 2004-12-02 | Emisphere Technologies, Inc. | Compositions for delivering peptide YY and PYY agonists |
US8008255B2 (en) | 2003-05-30 | 2011-08-30 | Amylin Pharmaceuticals, Inc. | Methods and compositions for enhanced transmucosal delivery of peptides and proteins |
US7274740B2 (en) * | 2003-06-25 | 2007-09-25 | Sharp Laboratories Of America, Inc. | Wireless video transmission system |
US20050091693A1 (en) * | 2003-10-22 | 2005-04-28 | Rochelle Communications, Inc. | Dual mode set-top box that optimizes the delivery and user selection of audio or video programming over data networks |
US7151097B2 (en) | 2003-11-07 | 2006-12-19 | Pfizer Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
EA010369B1 (ru) | 2004-02-04 | 2008-08-29 | Пфайзер Продактс Инк. | Замещенные хинолиновые соединения |
JP5638177B2 (ja) * | 2004-02-11 | 2014-12-10 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド |
EP1718671A2 (fr) * | 2004-02-23 | 2006-11-08 | Rheoscience A/S | Analogues du peptide yy |
US7954129B2 (en) * | 2004-09-24 | 2011-05-31 | Smartvue Corporation | Wireless video surveillance system and method with remote viewing |
US20060088105A1 (en) * | 2004-10-27 | 2006-04-27 | Bo Shen | Method and system for generating multiple transcoded outputs based on a single input |
US7620065B2 (en) * | 2005-07-22 | 2009-11-17 | Trellia Networks, Inc. | Mobile connectivity solution |
US8189472B2 (en) * | 2005-09-07 | 2012-05-29 | Mcdonald James F | Optimizing bandwidth utilization to a subscriber premises |
-
2006
- 2006-01-24 PA PA20068660701A patent/PA8660701A1/es unknown
- 2006-01-27 TW TW095103474A patent/TWI310038B/zh not_active IP Right Cessation
- 2006-01-30 JP JP2007553737A patent/JP4314304B2/ja not_active Expired - Fee Related
- 2006-01-30 BR BRPI0606142-7A patent/BRPI0606142A2/pt not_active IP Right Cessation
- 2006-01-30 CA CA2596977A patent/CA2596977C/fr not_active Expired - Fee Related
- 2006-01-30 RS RSP-2009/0210A patent/RS50966B/sr unknown
- 2006-01-30 DE DE602006005902T patent/DE602006005902D1/de active Active
- 2006-01-30 WO PCT/IB2006/000270 patent/WO2006082517A1/fr active Application Filing
- 2006-01-30 EP EP09155624A patent/EP2078729A1/fr not_active Withdrawn
- 2006-01-30 PL PL06710361T patent/PL1846445T3/pl unknown
- 2006-01-30 PT PT06710361T patent/PT1846445E/pt unknown
- 2006-01-30 ES ES06710361T patent/ES2322293T3/es active Active
- 2006-01-30 MX MX2007009389A patent/MX2007009389A/es active IP Right Grant
- 2006-01-30 DK DK06710361T patent/DK1846445T3/da active
- 2006-01-30 EA EA200701439A patent/EA011882B1/ru not_active IP Right Cessation
- 2006-01-30 AP AP2007004069A patent/AP2007004069A0/xx unknown
- 2006-01-30 EP EP06710361A patent/EP1846445B1/fr active Active
- 2006-01-30 SI SI200630252T patent/SI1846445T1/sl unknown
- 2006-01-30 AU AU2006211039A patent/AU2006211039A1/en not_active Abandoned
- 2006-01-30 KR KR1020077017974A patent/KR100892545B1/ko not_active IP Right Cessation
- 2006-01-30 AT AT06710361T patent/ATE426614T1/de not_active IP Right Cessation
- 2006-02-01 DO DO2006000025A patent/DOP2006000025A/es unknown
- 2006-02-01 PE PE2006000128A patent/PE20061412A1/es not_active Application Discontinuation
- 2006-02-02 UY UY29357A patent/UY29357A1/es not_active Application Discontinuation
- 2006-02-02 GT GT200600038A patent/GT200600038A/es unknown
- 2006-02-02 AR ARP060100377A patent/AR052108A1/es unknown
- 2006-02-03 NL NL1031067A patent/NL1031067C2/nl not_active IP Right Cessation
- 2006-02-03 US US11/347,730 patent/US20060178501A1/en not_active Abandoned
-
2007
- 2007-03-01 NL NL1033469A patent/NL1033469C2/nl not_active IP Right Cessation
- 2007-07-01 IL IL184324A patent/IL184324A0/en unknown
- 2007-08-03 MA MA30123A patent/MA29243B1/fr unknown
- 2007-08-03 TN TNP2007000305A patent/TNSN07305A1/fr unknown
- 2007-09-04 NO NO20074498A patent/NO20074498L/no not_active Application Discontinuation
-
2009
- 2009-02-26 US US12/393,259 patent/US20090171071A1/en not_active Abandoned
- 2009-02-26 US US12/393,420 patent/US20090170778A1/en not_active Abandoned
- 2009-04-24 HR HR20090245T patent/HRP20090245T1/xx unknown
- 2009-05-12 CY CY20091100507T patent/CY1109054T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29243B1 (fr) | Agonistes de pyy et leurs utilisations | |
CY1118007T1 (el) | Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων | |
TW200719913A (en) | Anti-madcam antibody compositions | |
MA30910B1 (fr) | Anticorps et immunoconjugues, et leurs utilisations | |
MA29528B1 (fr) | Agents de fixation | |
MA31898B1 (fr) | Compositions pharmaceutiques | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
MA30922B1 (fr) | Anticorps d'agonistes de trkb et leurs utilisations | |
EA201300246A1 (ru) | Ингибиторы тирозинкиназы брутона | |
MX2007010560A (es) | Roflumilast para el tratamiento de diabetes mellitus. | |
MA29788B1 (fr) | Combinaisons comprenant un inhibiteur des recepteurs vegf | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
UA97346C2 (ru) | Стабильная эмульсионная композиция | |
EA200800889A1 (ru) | Гексагидроциклооктилпиразольные каннабиноидные модуляторы | |
EA200900767A1 (ru) | Антагонистические антитела против ephb3 | |
DK1948155T3 (da) | Farmaceutiske præparater omfattende droxidopa | |
TW200621160A (en) | Anti-termite agent | |
WO2007067519A3 (fr) | Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees | |
BRPI0608287A2 (pt) | agente endoparasiticida | |
FR2879459B1 (fr) | Composition comprenant de l'adapalene solubilise avec des cyclodextrines | |
CL2007003451A1 (es) | Composicion farmaceutica solida oral que comprende un principio activo y polivinilpirrolidona (pvp) entre 1,0-25%, cpaa entre 0,5-10%, el principio activo consiste en una sal hidrosoluble de metal alcalino, de metal alcalino-terreo, una sal de mezcla | |
EA200970338A3 (ru) | Агонисты рецептора еро человека, композиции, способы и применение для предотвращения или лечения состояний, связанных с интолерантностью к глюкозе | |
EA200800820A1 (ru) | Композиция с замедленным высвобождением и ее применение | |
CR9917A (es) | Moduladores de cannabinoides hexahidro-cicloheptapirazol | |
IL185653A0 (en) | Pharmaceutical compositions containing an antibody which binds the stalk region of kim-1 |